ROS1 rearrangement: the latest class of non-small-cell lung cancer tumor

被引：0
|
作者：
Miller, Sarah
机构：
来源：
PHARMACOGENOMICS | 2012年 / 13卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [21] Erratum to: ROS1 gene rearrangement and copy number gain in non-small cell lung cancer
    Yan Jin
    Ping-Li Sun
    Hyojin Kim
    Eunhyang Park
    Hyo Sup Shim
    Sanghoon Jheon
    Kwhanmien Kim
    Choon-Taek Lee
    Jin-Haeng Chung
    Virchows Archiv, 2015, 467 : 123 - 123
  • [22] The Evolving Context of Driver Mutations: ROS1 Rearrangement in Metastatic Non-Small Cell Lung Cancer
    DeCaire, Ximena
    Streu, Erin
    ONCOLOGY NURSING FORUM, 2016, 43 (05) : 544 - 547
  • [23] Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement
    Lim, Sun Min
    Kim, Hye Ryun
    Lee, Jong-Seok
    Lee, Ki Hyeong
    Lee, Yun-Gyoo
    JooMin, Young
    Cho, Eun Kyung
    Lee, Sung Sook
    Kim, Bong-Seog
    Choi, Moon Young
    Shim, Hyo Sup
    Chung, Jin-Haeng
    La Choi, Yoon
    Lee, Min Jeong
    Kim, Maria
    Kim, Joo-Hang
    Ali, Siraj M.
    Ahn, Myung-Ju
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2613 - +
  • [24] Zeroing in on ROS1 Rearrangements in Non-Small Cell Lung Cancer
    Stumpfova, Magda
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4222 - 4224
  • [25] Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer
    Itchins, M.
    Alexander, M.
    John, T.
    Kao, S.
    Hughes, B.
    Hayes, S.
    Howel, V.
    Harvie, R.
    Clarke, S.
    Millward, M.
    Pavlakis, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S684 - S684
  • [26] Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study)
    Janzic, Urska
    Maimon Rabinovich, Natalie
    Shalata, Walid
    Kian, Waleed
    Szymczak, Katarzyna
    Dziadziuszko, Rafal
    Jakopovic, Marko
    Mountzios, Giannis
    Pluzanski, Adam
    Araujo, Antonio
    Charpidou, Andriani
    Daher, Sameh
    Agbarya, Abed
    CURRENT ONCOLOGY, 2024, 31 (08) : 4369 - 4381
  • [27] ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy
    Rose, Rafael
    Karachaliou, Niki
    Wolf, Juergen
    Ou, Sal-Hong Ignatius
    LANCET RESPIRATORY MEDICINE, 2014, 2 (12): : 966 - 968
  • [28] Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer
    Ginestet, Florent
    Lambros, Laetitia
    Le Flahec, Glen
    Marcorelles, Pascale
    Uguen, Arnaud
    CLINICAL LUNG CANCER, 2018, 19 (05) : E647 - E653
  • [29] The Study of ROS1 Rearrangement in Advanced Primary Non-Small Cell Lung Cancer and Associated Metastatic Lesions
    Xu, C.
    Wang, W.
    Zhuang, W.
    Tian, Y.
    Zhang, J.
    Wang, L.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2247 - S2247
  • [30] ROS1 rearrangement in non-small cell lung cancer (NSCLC): Prognostic and predicitve impact and genetic variability
    Scheffler, M.
    Schultheis, A.
    Michels, S.
    Teixido, C.
    Hartmann, W.
    Merkelbach-Bruse, S.
    Sebastian, M.
    Serke, M.
    Kropf-Sanchen, C.
    Wittersheim, M.
    Puetz, K.
    Binot, E.
    Schildhaus, H. -U.
    Heukamp, L. C.
    Rosell, R.
    Buettner, R.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 66 - 66
12345